DHR

What Wall St. Knows About Danaher Today.

Shares of Danaher have moved 1.8% today, and are now trading at a price of $221.35. In contrast, the S&P 500 index saw a 0.0% change. Today's trading volume is 2,089,162 compared to the stock's average volume of 3,146,090.

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. Based in Washington, United States the company has 79,000 full time employees and a market cap of $163,561,488,384. Danaher currently offers its equity investors a dividend that yields 0.5% per year.

The company is now trading 0.57% away from its average analyst target price of $220.09 per share. The 21 analysts following the stock have set target prices ranging from $185.62 to $259.87, and on average give Danaher a rating of buy.

Over the last 12 months DHR shares have declined by -10.3%, which represents a difference of -25.7% when compared to the S&P 500. The stock's 52 week high is $249.59 per share and its 52 week low is $182.09. Based on Danaher's average net margin growth of 11.0% over the last 6 years, its core business remains strong and the stock price may recover in the long term.

Date Reported Total Revenue ($ k) Net Profit ($ k) Net Margins (%) YoY Growth (%)
2023 29,566,000 7,209,000 24 4.35
2022 31,471,000 7,209,000 23 4.55
2021 29,453,000 6,433,000 22 37.5
2020 22,284,000 3,646,000 16 -5.88
2019 17,911,000 3,008,000 17 30.77
2018 19,893,000 2,653,100 13
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS